✦ LIBER ✦

Treatment of 11 patients with chronic myelogenous leukemia with interferon-alpha-2C and low-dose cytosine arabinoside

✍ Scribed by J. Thaler; T. Fluckinger; H. Huber; A. Lang; C. Abbrederis; H. Seewann; H. Silly; C. Baldinger; C. Duba; C. Huber; D. Niederwieser

Book ID: 113239762
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 459 KB
Volume: 17
Category: Article
ISSN: 0145-2126
DOI: 10.1016/0145-2126(93)90079-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of Philadelphia chromosome–pos

Treatment of Philadelphia chromosome–positive chronic myelogenous leukemia with weekly polyethylene glycol formulation of interferon-alpha-2b and low-dose cytosine arabinoside

✍ Guillermo Garcia-Manero; Moshe Talpaz; Francis J. Giles; Jorge Cortes; Stefan Fa 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

## Abstract ## BACKGROUND To evaluate the activity and toxicity of weekly Schering 54301, a polyethylene glycol formulation of interferon‐ α‐2b (PEG‐IFN‐α‐2b), with cytosine arabinoside (ara‐C) in patients with chronic myelogenous leukemia (CML). ## METHODS Seventy‐six patients with Philadelphia

Treatment of the blastic phase of chroni

Treatment of the blastic phase of chronic myelogenous leukemia with mitoxantrone and high-dose cytosine arabinoside

✍ Hagop M. Kantarjian; Ronald S. Walters; Michael J. Keating; Moshe Talpaz; Borje 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 511 KB

Treatment of chronic myelogenous leukemi

Treatment of chronic myelogenous leukemia with interferons alpha and gamma

✍ Kloke, O. ;May, D. ;Wandl, U. ;Becher, R. ;Opalka, B. ;Beer, U. ;Niederle, N. 📂 Article 📅 1990 🏛 Springer-Verlag ⚖ 175 KB

Bronchiolitis obliterans organizing pneu

Bronchiolitis obliterans organizing pneumonia in a patient with chronic myelogenous leukemia developing after initiation of interferon and cytosine arabinoside

✍ Meera Patel; Wendelin Ezzat; Kathy L. Pauw; Robert Lowsky 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB

Combination therapy with interferon-alph

Combination therapy with interferon-alpha-2b and hydroxyurea in patients with chronic myelogenous leukemia

✍ Eleftheria Chr Hatzimichael; Konstantinos L Bourantas 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Treatment of “poor risk” acute nonlympho

Treatment of “poor risk” acute nonlymphocytic leukemia with continuously infused low-dose cytosine arabinoside

✍ Dr. Edward P. Balaban; John V. Cox; Nancy R. Schneider; Cheryl A. Harth; Barbara 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 431 KB 👁 2 views